Shire PLC (LON:SHP)‘s stock had its “outperform” rating restated by research analysts at Credit Suisse Group AG in a research report issued on Friday. They currently have a GBX 5,200 ($67.88) target price on the biopharmaceutical company’s stock. Credit Suisse Group AG’s price target suggests a potential upside of 0.08% from the stock’s previous close.

A number of other research firms have also recently issued reports on SHP. Deutsche Bank AG restated a “buy” rating and set a GBX 6,000 ($78.32) price target on shares of Shire PLC in a report on Wednesday, July 13th. Liberum Capital restated a “buy” rating and set a GBX 5,500 ($71.79) price target on shares of Shire PLC in a report on Friday, July 29th. Goldman Sachs Group Inc. restated a “conviction-buy” rating and set a GBX 6,300 ($82.23) price target on shares of Shire PLC in a report on Thursday, September 29th. BNP Paribas restated an “outperform” rating and set a GBX 5,700 ($74.40) price target on shares of Shire PLC in a report on Monday, August 1st. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 5,800 ($75.71) target price on shares of Shire PLC in a report on Wednesday, July 6th. One analyst has rated the stock with a sell rating, one has given a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of GBX 5,828 ($76.07).

Analyst Recommendations for Shire PLC (LON:SHP)

Shares of Shire PLC (LON:SHP) traded up 1.60% during trading on Friday, reaching GBX 5196.00. 2,389,832 shares of the company were exchanged. The company’s market capitalization is GBX 35.48 billion. Shire PLC has a one year low of GBX 2,707.19 and a one year high of GBX 5,377.00. The firm’s 50 day moving average price is GBX 4,985.70 and its 200 day moving average price is GBX 4,560.67.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

The company also recently declared a dividend, which will be paid on Friday, October 7th. Stockholders of record on Thursday, September 8th will be paid a dividend of GBX 3.51 ($0.05) per share. The ex-dividend date is Thursday, September 8th. This represents a dividend yield of 0.07%.

In other news, insider Dominic Blakemore purchased 133 shares of the business’s stock in a transaction dated Friday, September 30th. The stock was bought at an average price of GBX 5,010 ($65.40) per share, for a total transaction of £6,663.30 ($8,697.69).

About Shire PLC

Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with's FREE daily email newsletter.